The widespread use of amidine and guanidine bases in synthetic chemistry merits a thorough understanding of their chemical properties. The propensity of these reagents to hydrolyze under mild conditions and generate aminolactams and aminoureas, respectively, has not been adequately described previously. During the synthesis of uprifosbuvir (MK-3682), we became aware of this liability for 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) by observing the formation of an unexpected reaction impurity and traced the root cause to low levels of N-(3-aminopropyl)-ε-caprolactam present in the commercial bottle. A controlled stability study over a period of two months at 25 °C demonstrated that, above a threshold water content, DBU steadily hydrolyzed over time. Rates of hydrolysis for DBU, 1,5-diazabicyclo[4.3.0]non-5-ene (DBN), 7-methyl-1,5,7triazabicyclo[4.4.0]dec-5-ene (MTBD), 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD), and N,N,N′,N′-tetramethylguanidine (TMG) in organic, aqueous, and mixed solvent systems were then measured to gain a more general appreciation of what conditions to avoid in order to maintain their integrity. Our findings indicate that these bases are hydrolytically unstable in unbuffered and very basic solutions but become significantly more stable in buffered solutions at pH values below 11.6.
The thermogravimetry (TG) results (Figure 1) for Form A were obtained at a heating rate of 10 °C/min under nitrogen atmosphere. A weight loss of 0.07% was observed up to 100.6C and 0.82% up to 254.2C . Differential scanning calorimetry (DSC) results (Figure 2) for Form A were collected at a heating rate of 10 °C/min, under nitrogen atmosphere in an open pan. No melting transition was observed.
An efficient route to the HCV antiviral agent uprifosbuvir was developed in 5 steps from readily available uridine in 50% overall yield. This concise synthesis was achieved by development of...
We
report a practical 3′,5′-diprotection strategy
suitable for the kilogram-scale preparation of 2′-C-methyl-arabino-uridine, a key intermediate in the
synthesis of the HCV NS5B inhibitor uprifosbuvir. Starting from uridine,
dipivaloylation afforded an ∼2:1 mixture of 3′,5′-
and 2′,5′-dipivaloyluridine. Subjecting this mixture
to TEMPO/bleach oxidation promoted a dynamic acylation migration–selective
oxidation to afford the 2′-ketone in 65% yield. Alternatively,
treatment with 1 equiv of BF3 etherate led to the crystallization-driven
equilibration and precipitation of 3′,5′-dipivaloyluridine·BF3 complex in a >50:1 ratio. After salt break, this mixture
was oxidized in the presence of TEMPO/AcOOH to afford the 2′-ketone
in 90% yield. Subsequent α-facial-selective methylation with
MeMgBr/MnCl2 afforded 3′,5′-dipivaloylated
2′-C-methyl-arabino-uridine 12. This three-step process was successfully demonstrated
on a multikilogram scale to afford the key intermediate for the manufacture
of uprifosbuvir.
A simple and efficient process to prepare Uprifosbuvir intermediate, 2′-deoxy-α-2′-chloro-β-2′-methyluridine (1), from bis-pivaloyl tertiary alcohol 5a is described. The key discoveries are a novel BSA-promoted anhydrouridine formation catalyzed by HCl as an additive and a milder safe Me 2 SiCl 2 -promoted chlorination of anhydrouridine. These discoveries collectively enabled the establishment of a robust process toward compound 1, which was demonstrated successfully at the plant scale.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.